Urinary Cadmium Levels Linked to Cognitive Impairment in Whites
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Sept. 4, 2024 -- Among White, but not Black individuals, urinary cadmium (Cd) concentrations are associated with cognitive impairment, according to a study published online Sept. 4 in Neurology.
Liping Lu, M.D., Ph.D., from the Mailman School of Public Health at Columbia University in New York City, and colleagues examined the association between urinary Cd concentration and cognitive impairment in a subcohort of REasons for Geographic and Racial Differences in Stroke study participants who were free of cognitive impairment or stroke at baseline.
The analyses included 2,172 participants with available data on urinary Cd concentration, including 195 cases of global cognitive impairment and 53 cases of domain-based cognitive impairment. In the full sample, the researchers observed no association between Cd and cognitive impairment, but a significant positive association of urinary Cd concentration with global cognitive impairment was seen among White but not Black participants. In the high versus low urinary Cd group, the odds of cognitive impairment for White participants were doubled (odds ratio, 2.07). The associations of interest were not materially modified by sex, age, region, smoking pack-years, alcohol consumption, or other related metals.
"These results need to be confirmed with studies that measure cadmium levels over time, include more people and follow people over a longer time, but there are many reasons to reduce exposure to cadmium, whether it's through implementing policies and regulations for air pollution and drinking water or people changing their behaviors by stopping smoking or being around cigarette smoke," Lu said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk
TUESDAY, April 29, 2025 -- An intensive blood pressure (BP) reduction intervention is effective for lowering the risk for all-cause dementia among individuals aged 40 years and...
32 Percent of Dementia Attributed to Audiometric Hearing Loss
MONDAY, April 28, 2025 -- The population attributable fraction of dementia from any audiometric hearing loss is 32.0 percent, according to a study published online April 17 in...
Moderately Preterm Birth Tied to Long-Term Cognitive Problems
FRIDAY, April 25, 2025 -- Moderately preterm birth is associated with cognitive problems at ages 9 to 10 years, according to a study published online April 14 in JAMA Network...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.